Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

How do you feel today about SQQQ?

Investing.com -- Shares of Clearwater Paper Corp . (NYSE:CLW) surged 15% following reports that Brazil's Suzano SA is considering a takeover bid for the company. According to Bloomberg, Suzano is ...

Investing.com -- TD Cowen analysts upgraded BlackBerry (NYSE:BB) shares on Friday after the cybersecurity software firm delivered solid financial results for the fiscal third quarter a day earlier.

Investing.com -- US stock futures fell Friday as the threat of a US government shutdown increased, and as investors awaited the release of key inflation data. Here are some of the biggest premarket US ...

Investing.com -- Shares of Occidental Petroleum (NYSE:OXY), Sirius XM Holdings (NASDAQ:SIRI), and VeriSign (NASDAQ:VRSN) saw an uptick in the trading session following news of Berkshire Hathaway (NYSE ...

Investing.com -- Aadi Bioscience, Inc. (NASDAQ:AADI) shares surged 24% in pre-open trading Friday following the company's announcement of a strategic licensing agreement and a significant asset sale.

Investing.com -- President-elect Donald Trump warned that the European Union (EU) must significantly increase its purchases of American oil and gas or face tariffs on European imports. “I told the ...

Investing.com -- Bitcoin's value plummeted approximately 9% on Friday, as the cryptocurrency market experienced a sharp sell-off, possibly reflecting a broader investor retreat from risk assets. The ...

Investing.com -- Former Nissan (OTC:NSANY) Motor Co. chairman, Carlos Ghosn, has commented on the potential deal between Nissan and Honda Motor Co (NYSE:HMC)., labeling it a "desperate move". Ghosn ...

Investing.com -- Shares of Novo Nordisk (NYSE:NVO) A/S, the Danish pharmaceutical company, experienced a significant drop following the release of less than anticipated results from a study of its ...

Investing.com -- Shares of Novo Nordisk (NYSE:NVO) plummeted over 19% in premarket trading Friday after the results from its phase 3 trial of CagriSema, its next-generation obesity drug, disappointed.